Corrigendum to 'FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide' [Journal of Molecular and Cellular Cardiology volume 210 (2026) 12-27].
- DOI
- 10.1016/j.yjmcc.2025.11.015
- Published
- 2026 Feb
- Container
- Journal of molecular and cellular cardiology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.yjmcc.2025.11.015,
title = {Corrigendum to 'FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide' [Journal of Molecular and Cellular Cardiology volume 210 (2026) 12-27].},
author = {Sánchez-López D and García-Vega D and Viñuela JE and Ferreirós-Vidal I and Iglesias-Álvarez D and Martínez-Cereijo JM and Reija-López L and Fernández-González ÁL and González-Juanatey JR and Eiras S},
year = {2026},
journal = {Journal of molecular and cellular cardiology},
doi = {10.1016/j.yjmcc.2025.11.015},
url = {https://doi.org/10.1016/j.yjmcc.2025.11.015}
}RIS
TY - JOUR TI - Corrigendum to 'FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide' [Journal of Molecular and Cellular Cardiology volume 210 (2026) 12-27]. AU - Sánchez-López D AU - García-Vega D AU - Viñuela JE AU - Ferreirós-Vidal I AU - Iglesias-Álvarez D AU - Martínez-Cereijo JM AU - Reija-López L AU - Fernández-González ÁL AU - González-Juanatey JR AU - Eiras S PY - 2026 JO - Journal of molecular and cellular cardiology DO - 10.1016/j.yjmcc.2025.11.015 UR - https://doi.org/10.1016/j.yjmcc.2025.11.015 ER -
APA
D, S., D, G., JE, V., I, F., D, I., JM, M., L, R., ÁL, F., JR, G., & S, E. (2026). Corrigendum to 'FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide' [Journal of Molecular and Cellular Cardiology volume 210 (2026) 12-27].. Journal of molecular and cellular cardiology. https://doi.org/10.1016/j.yjmcc.2025.11.015
Source records
- pubmed · retrieved 2026-09-26T21:49:19.169Z